Philip Morris International Inc. announced that on January 16, 2025, the U.S. Food and Drug Administration (FDA) authorized **ZYN**, a nicotine pouch produced by Swedish Match North America, LLC (a subsidiary of Philip Morris International), as the first nicotine pouch to receive FDA authorization in the United States. This significant decision is expected to enhance the product's credibility and availability in the nicotine pouch market. Swedish Match North America issued a press release detailing the decision, which is attached as Exhibit 99.1 to the current Form 8-K report. However, the information provided in this announcement, including the exhibit, is not deemed "filed" under the Securities Exchange Act of 1934 and cannot be incorporated into other filings unless explicitly stated. The announcement highlights Philip Morris International's ongoing efforts to expand its product portfolio and promote alternatives to traditional tobacco products.